Inventor
BYOUNG S. KWON
Inventor
KR
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
A61KPreparations for medical, dental or toiletry purposes25%
C12NMicroorganisms or enzymes17%
PatentTitleYear
12,559,538PD-1 polypeptide variants202612,331,116Bispecific epitope binding protein comprising anti-4-1BB antibody and a PD-1 protein or fragments thereof and use thereof202512,122,845Anti-HER2/anti-4-1BB bispecific antibodies and uses thereof202411,951,130Chimeric antigen receptor that binds HLA-DR and CAR-T cell202411,905,334Anti-human VSIG4 antibodies and uses thereof202411,859,004Anti-human 4-1BB antibodies and uses thereof202411,395,836Cancer antigen specific cytotoxic T cell2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to EUTILEX CO LTD (7)· patent assignee history
2022–2026Based in KR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| EUTILEX CO LTD | 7 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 7 | 2022–2026 |